← Leaderboards
Aniket Ramshekar
University Of Utah
$116,011
Attributed
$116,011
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $43.8K · FY2021–23$50K$37.5K$25K$12.5K$0
'21
'22
'23
Funding mix
By agency
NIH$116,011 · 1
By mechanism
F30$116,011 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Utah
Same institution · by research overlap
- Monica L Vetter$16,742,874
- Robert E Marc$15,329,042
- Yingbin Fu$5,386,081
- Weiquan (wendy) Zhu$2,932,948
- Grant J Jensen$18,127,842
Others in their field
Other Emerging Leaders on “Adult”
- Beth Baseler · Leidos Biomedical Research, Inc.$127,607,354
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$93,592,175
- Susan M Landau · University Of California Berkeley$47,252,026
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,295,422
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Evan Z Macosko · Broad Institute, Inc.$32,116,761
Research focus
AdultGuanosine Triphosphate PhosphohydrolasesAdverse EffectsBinding ProteinsAngiogenesisGtp BindingCell MotilityBindingChoroidChoroidal NeovascularizationBlindnessCo-ImmunoprecipitationsBlood VesselsCyclic AmpEndothelial CellsEndotheliumEventExudative Age-Related Macular DegenerationFellowshipFlow CytometryGenerationsGrowthGrowth Factor InhibitionHomeostasis
Grant awards (3)
Investigating the role of active Rap1a binding IQGAP1 in choroidal neovascularization$43,797
F30 · FY2023 · EY · contact PI
Investigating the role of active Rap1a binding IQGAP1 in choroidal neovascularization$36,465
F30 · FY2022 · EY · contact PI
Investigating the role of active Rap1a binding IQGAP1 in choroidal neovascularization$35,749
F30 · FY2021 · EY · contact PI